31. 叢發性頭痛(cluster headache)急性發作時，下列何種藥物不具治療角色?
(A)皮下注射 sumatriptan
(B)經鼻給予 zolmitriptan
(C)經鼻給予 lidocaine 至翼齶窩(pterygopalatine fossa)
(D)靜脈注射 dihydroergotamine
(E)口服 verapamil

20. 叢發性頭痛(cluster headache)急性發作時，下列何種藥物不具治療角色? (A) 皮下注射 sumatriptan (B) 經鼻給予 zolmitriptan (C) 經鼻給予 lidocaine 至翼齶窩（pterygopalatine fossa） (D) 靜脈注射 dihydroergotamine (E) 口服 verapamil

18.叢發性頭痛(cluster headache)急性發作時，下列何種藥物不具治療角色? (A)皮下注射 sumatriptan (B)經鼻給予 zolmitriptan (C)經鼻給予 lidocaine 至翼齶窩（pterygopalatine fossa） (D)靜脈注射 dihydroergotamine (E)口服 verapamil

32. 下列何者不是偏頭痛(migraine)常見症狀？ (A)單側性疼痛 (B)搏動性疼痛 (C)痛到眼窩後方 (D)噁心嘔吐 (E)對光與聲音敏感

33. 下列何者不是典型三叉神經痛(classic trigeminal neuralgia)的臨床特徵? (A)發作前常無預兆 (B)表淺的、尖銳的、針刺樣或撕裂樣的劇烈疼痛 (C)持續超過 10 分鐘以上 (D)在個別患者發作型態變化不大 (E)無神經缺陷

34. 下列何者為最常見的頭痛型態？ (A)偏頭痛(migraine) (B)緊張性頭痛(tension-type headaches) (C)叢集性頭痛(cluster headaches) (D)頸因性頭痛(cervicogenic headache) (E)次發性頭痛(Secondary headaches)

35. 下列關於原發性口腔灼熱症候群(burning mouth syndrome)的描述，何者為非? (A)症狀局限於舌頭處 (B)表現灼熱及感覺異常 (C)常伴隨味覺功能障礙 (D)涉及對感覺神經元和自主神經元的損害 (E)藥物治療包含三環類抗抑鬱藥、抗癲癇藥或鴉片類藥物

36. Which of the following statement concerning painful polyneuropathies with prevalent loss of small fibres is most likely: (A) Chronic renal failure neuropathy. I. (B) Diabetes mellitus neuropathy. (C) Alcoholic neuropathy. (D) Myeloma neuropathy.. (E) soniazid neuropathy.

37. Which of the following is the acceptable statement about neurodestructive RF lesions? (A) These temperatures are resulted from friction heat. (B) The size of RF lesion with 22 gauge RF needle is around with a radius of 5 mm (C) The heat is generated on the tip of RF needle. The RF needle then heat up the tissues. (D) The RF pernanent neuro-destructive lesion is formed when neural temperatures exceed 42 C (E) All of the above

38. Which of the following suggestion is not advisable for the use of opioids in children with cancre pain? (A) Use the oral route first in most circumstances (B) Treat constipation pre-emptively. (C) If side effects are bothersome with one opioid, consider switching to another one. (D) Use sufficient doses to keep the patient comfortable should be avoided due to the possible occurrence of adverse effects (E) Use the oral route first in most circumstances.

39. Which of the following is not a common manifestation of the myofascial pain syndrome? (A) Regional body pain and stiffness (B) Abnormal findings on neurological examinationl (C) Limited range of motion of the affected muscle (D) One or more trigger points (E) Referral (triggering) pain from a trigger point to a zone of reference .

112年 - 112 台灣疼痛醫學會專科醫師考題#116972

111年 - 111 台灣疼痛醫學會專科醫師考題#116969

110年 - 110 台灣疼痛醫學會專科醫師考題 #120829

109年 - 109 台灣疼痛醫學會專科醫師考題#120915

108年 - 108 台灣疼痛醫學會專科醫師考題#122407

107年 - 台灣疼痛醫學會專科醫師考題#122426

106年 - 106 台灣疼痛醫學會專科醫師考題#122412

105年 - 105 台灣疼痛醫學會專科醫師考題#122415

104年 - 104 台灣疼痛醫學會專科醫師考題#122433

103年 - 103 台灣疼痛醫學會專科醫師考題#125057